2024 - Leveraging Real-World Data: Insights into Depression from Surveys and Wearables
Date2024-11-08
Deadline2024-11-08
VenueONLINE-VIRTUAL, USA - United States
KeywordsLife Sciences; Pharmaceutical; Drug Discovery & Development
Topics/Call fo Papers
To better address the impact of depression on the well-being and quality of life, treatment approaches and clinical trials can benefit from information about the everyday experiences and challenges of individuals with depression. Equally important is understanding how these experiences change over time and with treatment. Gaining these insights relies on longitudinal data collected from a large, representative, real-world population, which can be difficult to achieve in clinical trial and care settings.
A continuous, direct connection to an online community of engaged individuals willing to respond to surveys and connect their devices and apps, such as Apple Watches and Fitbits, presents opportunities to capture data longitudinally. These novel, layered datasets help accurately and comprehensively describe the real-world experiences with depression and psycho- and pharmacotherapy.
Using this approach, Evidation collected survey data from over 54,000 individuals and sleep and activity data from more than 35,000 individuals who had a wearable device connected in the past 90 days. The methodology and insights from this large group of individuals with depression will be presented in this webinar.
The speaker will also delve into the key insights, demonstrating how real-world data can support more informed decision-making in depression-related clinical trials and treatment strategies.
Join this webinar to learn how real-world data can revolutionize understanding of depression and drive more patient-centered research and care.
Keywords: Drug Development, Wearables, Clinical Research, Depression, Wearable Device, Clinical Data, CNS, Major Depressive Disorder, Commercialization/HEOR/Market Access
A continuous, direct connection to an online community of engaged individuals willing to respond to surveys and connect their devices and apps, such as Apple Watches and Fitbits, presents opportunities to capture data longitudinally. These novel, layered datasets help accurately and comprehensively describe the real-world experiences with depression and psycho- and pharmacotherapy.
Using this approach, Evidation collected survey data from over 54,000 individuals and sleep and activity data from more than 35,000 individuals who had a wearable device connected in the past 90 days. The methodology and insights from this large group of individuals with depression will be presented in this webinar.
The speaker will also delve into the key insights, demonstrating how real-world data can support more informed decision-making in depression-related clinical trials and treatment strategies.
Join this webinar to learn how real-world data can revolutionize understanding of depression and drive more patient-centered research and care.
Keywords: Drug Development, Wearables, Clinical Research, Depression, Wearable Device, Clinical Data, CNS, Major Depressive Disorder, Commercialization/HEOR/Market Access
Other CFPs
- REMS Technology Innovation: Reducing Prescriber and Pharmacy Burden
- Medical Device Safety: Navigating Regulations and Standards to Determine Non-clinical Requirements
- Insights to Conducting Clinical Trials in Africa – A Shared Experience
- Optimizing Clinical Trial Protocols: How Digitized Protocols are Accelerating Clinical Research
- Pandemic Preparedness: Agility in Vaccine, Diagnostics and Therapeutics Development
Last modified: 2024-10-16 04:51:27